Former Chief Financial Officer · GoodRx Holdings, Inc. (GDRX)

Karsten Voermann

A named executive officer of GoodRx in every fiscal year CompBrief holds from FY2021 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$280,256

Salary $22,212Stock awards $0

FY2024: $5,836,601

6th of 6 named executive officers at GoodRx by FY2025 total.

6 named officers on file for GoodRx, FY2025

Karsten Voermann’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • GDRX’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how GoodRx’s whole pay program stands against its peers

  • GoodRx’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GDRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2026 (DEF 14A).

Free

Get Karsten Voermann’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Karsten Voermann compensation by year

GoodRx Summary Compensation Table · all 5 fiscal years held
In US dollars, as GoodRx reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024FY2025
Salary$428,000$439,000$450,000$450,000$22,212
Bonus$250$205,395$163,105$443$0
Stock awards$0$4,541,371$0$2,578,753$0
Option awards$0$0$0$2,499,997$251,805
Non-equity incentive$91,723$0$242,208$272,070$0
Pension and deferred compensation$0$0$0$0$0
All other$997$49,294$46,929$35,338$6,239
Total$520,970$5,235,060$902,242$5,836,601$280,256

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GoodRx Holdings, Inc. DEF 14A filed April 29, 2026, accession 0001809519-26-000091, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GoodRx Holdings, Inc. filed document, accession 0001809519-26-000091. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

$521K
$5.2M
$902K
$5.8M
$280K
FY21
FY22
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Change-in-control & termination

estimated payments GoodRx discloses, by trigger · FY2024
TriggerCash severanceAccelerated equityBenefits continuationTotal as disclosed
Involuntary termination without cause$450,000$0$26,907$476,907
Change in control and involuntary termination$450,000$1,420,797$26,907$1,897,704
Disability——$0$0
Death——$0$0
Resignation for good reason, no change in control$450,000$0$26,907$476,907
Change in control, no termination——$0$0
Change in control and resignation for good reason$450,000$1,420,797$26,907$1,897,704

Per the Potential Payments Upon Termination or Change in Control table in GoodRx Holdings, Inc.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.

GoodRx’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Wendy BarnesChief Executive Officer & President$23,367,483
Christopher McGinnisChief Financial Officer & Treasurer$8,698,916
Romin NabieyChief Accounting Officer and Former Interim Chief Financial Officer$1,256,668
Trevor BezdekCo-Chairman of the Board$971,608
Scott WagnerFormer Interim Chief Executive Officer$856,780
Karsten Voermann · this pageFormer Chief Financial Officer$280,256

The full GoodRx compensation record

free company brief

This page is one person within GoodRx's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GoodRx proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GoodRx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Karsten Voermann's compensation dossier · One-time report. No refunds.